Shuai Chen

1.6k total citations
63 papers, 1.2k citations indexed

About

Shuai Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shuai Chen has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 24 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Shuai Chen's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (13 papers) and interferon and immune responses (6 papers). Shuai Chen is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (13 papers) and interferon and immune responses (6 papers). Shuai Chen collaborates with scholars based in China, United States and South Korea. Shuai Chen's co-authors include Wenlin Huang, Chunjie Sheng, Chen Yao, Jiangxue Wu, Ziyang Wang, Ranyi Liu, Rong Geng, Jiaxin Lin, Xin Tan and Zhizhong Pan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shuai Chen

59 papers receiving 1.2k citations

Peers

Shuai Chen
Qianting He China
Н. В. Литвяков Russia
Stefano Caramuta Sweden
Jianhong Zuo China
Wei-Fan Chiang Taiwan
Hua‐Chien Chen Taiwan
Wenting Pan China
Xifa Zhou China
Xiaojie Li China
Qianting He China
Shuai Chen
Citations per year, relative to Shuai Chen Shuai Chen (= 1×) peers Qianting He

Countries citing papers authored by Shuai Chen

Since Specialization
Citations

This map shows the geographic impact of Shuai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Chen more than expected).

Fields of papers citing papers by Shuai Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Chen. The network helps show where Shuai Chen may publish in the future.

Co-authorship network of co-authors of Shuai Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Chen. A scholar is included among the top collaborators of Shuai Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Chen. Shuai Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Chenqi, et al.. (2025). Mendelian randomization analysis to identify potential drug targets for osteoarthritis. PLoS ONE. 20(2). e0316824–e0316824. 1 indexed citations
3.
4.
Sun, Xiaohe, et al.. (2024). Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study. Frontiers in Endocrinology. 15. 1284472–1284472. 4 indexed citations
5.
Zhang, Shimeng, Bingbing Yu, Chunjie Sheng, et al.. (2024). SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy. Advanced Science. 11(36). e2403019–e2403019. 13 indexed citations
6.
Sheng, Chunjie, et al.. (2024). Cyclophilin J limits linear ubiquitin signaling and controls colorectal cancer progression. Journal of Biological Chemistry. 300(9). 107610–107610. 2 indexed citations
7.
Zeng, Qi, Yao Chen, Shimeng Zhang, et al.. (2024). ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation. eLife. 13. 1 indexed citations
8.
Chen, Shuai, et al.. (2023). CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway. Scientific Reports. 13(1). 10956–10956. 5 indexed citations
9.
Sprague, Brian L., Shuai Chen, Diana L. Miglioretti, et al.. (2023). Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency. JAMA Network Open. 6(2). e230166–e230166. 1 indexed citations
10.
11.
Ma, Weijie, Bridget McLaughlin, Maria Jaimes, et al.. (2023). Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry. Frontiers in Immunology. 14. 1206631–1206631. 8 indexed citations
12.
Wang, Ziyang, et al.. (2021). Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma. Journal of Translational Medicine. 19(1). 161–161. 22 indexed citations
13.
Wang, Ziyang, et al.. (2021). Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells. Advanced Science. 8(10). 2004344–2004344. 62 indexed citations
14.
Chen, Shuai, Shuai Ren, Kai Guo, et al.. (2021). Preoperative differentiation of serous cystic neoplasms from mucin-producing pancreatic cystic neoplasms using a CT-based radiomics nomogram. Abdominal Radiology. 46(6). 2637–2646. 16 indexed citations
15.
Wang, Ziyang, et al.. (2020). ARHGEF19 regulates MAPK/ERK signaling and promotes the progression of small cell lung cancer. Biochemical and Biophysical Research Communications. 533(4). 792–799. 9 indexed citations
16.
Sheng, Chunjie, Ziyang Wang, Chen Yao, et al.. (2020). CALML6 Controls TAK1 Ubiquitination and Confers Protection against Acute Inflammation. The Journal of Immunology. 204(11). 3008–3018. 11 indexed citations
17.
Wang, Ziyang, et al.. (2020). RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF‐κB Activation. Advanced Science. 7(17). 2000593–2000593. 20 indexed citations
18.
19.
Chen, Qiu-Yan, Lin-Quan Tang, Li-Ting Liu, et al.. (2017). Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study. BMC Cancer. 17(1). 567–567. 22 indexed citations
20.
Zhang, Junlin, et al.. (2009). [Over-expression of phospholipase D3 inhibits Akt phosphorylation in C2C12 myoblasts].. PubMed. 25(10). 1524–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianting He Breakdown of academic impact, for papers by Н. В. Литвяков Breakdown of academic impact, for papers by Stefano Caramuta Breakdown of academic impact, for papers by Jianhong Zuo Breakdown of academic impact, for papers by Wei-Fan Chiang Breakdown of academic impact, for papers by Hua‐Chien Chen Breakdown of academic impact, for papers by Wenting Pan Breakdown of academic impact, for papers by Xifa Zhou Breakdown of academic impact, for papers by Xiaojie Li
Rankless by CCL
2026